Search jobs Compass Therapeutics Announces Participation in March 2021 Investor Conferences
BOSTON (BUSINESS WIRE) $CMPX#CompassTherapeutics Compass Therapeutics, Inc. (OTCQB: CMPX), a clinical-stage biotechnology company developing proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies, today announced that Thomas Schuetz, MD, PhD, Co-Founder and Chief Executive Officer of Compass Therapeutics, will participate in the following virtual investor conferences:
H.C. Wainwright Global Life Sciences Conference, March 9-10, 2021: Compass presentation will be broadcasted at 7:00 a.m. EST on March 9, 2021 and available on demand during the conference.
33rd Annual Roth Conference, March 15-17, 2021: as part of a live panel on bispecific antibodies that will take place at 3:00 p.m. EDT on Tuesday, March 16, 2021.
Quercis Pharma To Participate In HC Wainwright s Global Life Sciences Conference
Highlighting Novel Antithrombotic Platform and Late-Stage Clinical Development Programs in Cancer, COVID-19 and Sickle Cell Disease
News provided by
Share this article
Share this article
ZUG, Switzerland, March 5, 2021 /PRNewswire/ Quercis Pharma AG, a private, clinical stage biopharmaceutical company leveraging its novel antithrombotic platform, today announces that Company management will participate in the upcoming HC Wainwright Global Life Sciences Conference taking place virtually from March 9-10, 2021.
Ilias Läber, Ph.D., Chief Executive Officer, and Stefan Wohlfeil, M.D., Chief Medical Officer of Quercis Pharma, will deliver a corporate overview in a webcast presentation that will be available on-demand as of 6:00 a.m. EST, Tuesday, March 9, 2021 through 5:00 p.m. EST, Wednesday, March 10, 2021 at https://journey.ct.events/view/45210c25-28cc-4bc5-92d5-c974f8425b6d.
Trxade Group to Present at March Investor Conferences saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.
Share this article
BOSTON, March 5, 2021 /PRNewswire/
NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announced that Company management will participate in the upcoming H.C. Wainwright Global Life Sciences Conference taking place virtually from March 9-10, 2021.
Akash Bakshi, Senior Vice President and Chief Operating Officer of NeuroBo and Seth Reno, Commercial Advisor of NeuroBo, will present a corporate overview at the conference, including an update on the status of the ongoing phase 2/3 study of lead program, ANA001, in moderate and severe COVID-19 patients.
The presentation will be available beginning March 9, at 7:00 am ET. A webcast of the presentation will be available on the Events and Presentations section of NeuroBo s website at: neurobopharma.com/events-presentations. An archived replay will be available for a period of 90 days after the conference.
Trxade Group, Inc.: Trxade Group to Present at March Investor Conferences
, a technology-enabled health services platform company focused on digitalizing the retail pharmacy experience
, today announced that management will present at the following virtual investor conferences during the month of March 2021.
Suren Ajjarapu, Chief Executive Officer of Trxade Group, is scheduled to host pre-recorded virtual presentations during each of the conferences as follows and will participate in one-on-one meetings throughout the day at each event.
H.C. Wainwright Global Life Sciences Conference - Virtual
Date: March 9-10, 2021
ROTH Growth Stock Conference - Virtual
Date: March 15-17, 2021
Maxim Group Emerging Growth Conference - Virtual